BioNTech said that BNT327 has the "potential to replace current checkpoint inhibitor standard of care treatments for solid ...
Although it is seeing a downturn in sales and profits, German biotech BioNTech (Nasdaq: BNTX) is continuing to acquire assets ...
November 13th has seen a myriad of significant events throughout history, impacting various spheres such as politics, science ...
Recent health news highlights include Amgen addressing bone density concerns, AstraZeneca revising its financial outlook ...
BioNTech will make $800mn in upfront payments to Biotheus, a drugmaker based in Guangdong province, with milestone payments of up to $150mn. Uğur Şahin, chief executive of BioNTech, said the company ...
BioNTech is buying into one of the hottest areas of oncology, agreeing to pay $800 million to acquire China-based Biotheus ...
Hosted on MSN21h
Better Together: Making Magic Between Big Companies and StartupsIn response, Pfizer collaborated with BioNTech to create a vaccine capable of fighting the highly contagious Delta variant.
The FDA has lifted its clinical hold on Novavax's combined COVID-19 and influenza vaccine trial, finding no link between the ...
Stacker consulted research from Yale Medical School and the World Health Organization to find how SARS-CoV-2 has evolved ...
The Food and Drug Administration has lifted its clinical hold on a late-stage trial of Novavax's COVID-influenza and its ...
Findings highlight the Pfizer-BioNTech vaccine’s role in preventing MIS-C, a rare post-COVID inflammatory syndrome in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback